Lowest Price Guaranteed
Pages
407
Last Updated
July 2026
View Count
19539
One of the main reasons for choosing elastomeric materials for manufacturing closures is their anti-leaching property and limited interaction potential of the material with the formulation present in vial / syringe. Further, using ready-to-use products saves a lot of time and effort in the overall production processes
-- Project Manager, Business Development, a US based mid-sized company
The global pharmaceutical caps and closures market size is estimated to grow from USD 6.20 billion in 2024 to USD 12.49 billion by 2035, representing a higher CAGR of 6.6% during the forecast period till 2035.Caps and closures refer to the air-tight sealing products that have been designed to protect pharmaceutical drugs from moisture, dust and unfavorable climatic conditions. These caps and closures have been made using different types of materials such as metal, plastic and polymers.
 |
To learn more about this report, request a free sample copy
Pharmaceutical packaging plays a crucial role in ensuring the sterility and quality of a drug product, while also providing information related to its identity and, in certain cases, dosing instructions. Primary packaging material, owing to the fact that it is in immediate contact with the drug / therapy formulation, is considered to be extremely important when it comes to preserving the stability, efficacy and safety of the packaged drug product. Further, given the growing complexity of modern pharmacological interventions, especially biologics, it has become imperative for drug / therapy packaging considerations to be re-evaluated, taking into consideration the evident shift from large batches of one remedy for everyone to smaller batches of more personalized therapeutic solutions. In addition to optimizing drug-packaging compatibility, stakeholders in the pharmaceutical packaging industry have also adopted a number of other flexible solutions to reduce the overall cost and expedite time to market.
Drug spoilage due to enzymatic degradation, microbial spoilage, and environmental conditions has been a major concern for the pharmaceutical industries. As per the report of National Institutes of Health, the pharmaceutical drug wastage rate is anticipated to be around 3.68% which accounts for USD 159,762.66. Thus, the growing concern for pharmaceutical drug wastage has surged the demand for advanced caps and closures products that helps to keep the pharmaceutical products viable for extended period of time. Caps and closures also make handling convenient during pharmaceutical product transportation as well as improve the shelf life of packed drugs. It is important to highlight here that growing complexity of pharmaceutical products such as biologics and cell / gene therapies has surged the demand for innovative primary packaging material to ensure sterility of drugs. Given by the growing demand, pharmaceutical players are focusing on re-evaluating drug packaging solutions with improved caps & closure systems to maintain viability of drugs for long term.
It is interesting to highlight here that the industry leaders have begun to leverage elastomeric materials in caps and closures along with different types of coatings such as FluoroTec® and Teflon®. These elastomers offer several advantages such as protection from shedding, leaching of particulate contaminants and ensure minimal chemical interaction with pharmaceutical drug formulation. Furthermore, these elastomers can be used for the development of airtight and waterproof closures that are helpful for protecting drug formulation from environmental degradation. Moreover, such closures can also be manufactured in the ready-to-use (RTU) format, which saves a significant amount of time by eliminating the need for multiple steps in the overall fill / finish process.
In addition, several pharmaceutical leaders are emphasizing strategic initiatives followed by recent developments, collaborations, partnerships and investments to enhance product portfolios. For instance, in April 2024, SnapSlide introduced SnapSlide™ (The First Child-Resistant Closure) for Rx Amber Vials with single-handed operations, making is first ever adaptive packaging solution. Owing to the ongoing innovations in this industry and rising concern about drug wastage, we believe that pharmaceutical caps and closures market will grow at a healthy CAGR during the forecast period.
The research report highlights the valuable information about the leading companies who are presently active across different segments of this industry as mentioned in the table below.
| Key Report Attributes | Details | |
| Historical Trend | Since 2019 | |
| Forecast Period | Till 2035 | |
| Current Market Size | USD 6.20 Billion | |
| Market Size 2035 | USD 12.49 Billion | |
| CAGR | 6.6% | |
| Type of Packaging Containers |
|
|
| Type of Closure |
|
|
| Type of Sterilization Status |
|
|
| Key Geographical Region |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
|
|
The key objective of pharmaceutical caps and closures market report is to provide a detailed market analysis in order to estimate the existing market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunity during the forecast period. Based on several parameters, such as target consumer segments, region specific adoption rates and expected prices of such products, we have provided an informed estimate on the likely evolution of the market over the forecast period, till 2035. The market report provides sales forecasts for the overall elastomeric closures market, wherein both the current and upcoming opportunity is segmented across, type of packaging containers (vials, syringes and cartridges), type of closure (seal, stopper, cap, plunger, barrel and needles shield), sterilization status (pre-sterilized and unsterilized), and geographical region. In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
The opinions and insights presented in this market report was also influenced by discussions conducted with multiple stakeholders in pharmaceutical caps and closures market. The market research report features detailed transcripts of interviews held with the following individuals (in alphabetical order of company names):
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.
Based on the material, the pharmaceutical caps & closures market is segmented into plastic, metal, and others. According to our projection, currently, plastic material accounts for the highest share of the market. Plastic material is lightweight, flexible and can be molded into different shapes and designs, making it ideal for sealing drugs in wide range of packaging solutions. Furthermore, increasing demand for lightweight caps and packaging materials such as plastic and polymers has contributed towards the growth of this segment and is poised to grow at a higher CAGR during the forecast period. However, other materials like rubbers and glass closures will grow at a moderate CAGR during the projected period driven by the growing demand for storing parenteral drugs.
Based on the type of products, the caps and closures market is segmented into tethered caps, push / pull caps, screw caps, and others. According to our projection, currently, screw caps accounts for the highest share of the market. This is due to the fact that screw caps are easy to reseal and easy to apply on bottles and other drug storage containers. It is important to highlight here that industry leaders are driving innovations in screw caps to meet the evolving requirement for advanced containers and packaging solutions to maintain viability of drugs.
This segment highlights the distribution of pharmaceutical caps and closures market size on the basis of type of packaging containers into vials, syringes and cartridges. According to our projection, presently vials occupy the highest share of the market, capturing 41% of the overall revenue share. The dominance is primarily due to the extensive usage of vials in pharmaceutical industry for drug storage particularly liquid medications. However, syringes are expected to grow at a higher CAGR during the forecast period. This lucrative growth potential is due to the increasing demand for self-administered injectable drugs for chronic disease management. Additionally, the growing adoption of advanced drug delivery systems to deliver drugs, specifically biologics, at targeted site is likely to drive the demand for cartridges in the future.
Based on the type of closure, the global pharma caps & closures market is segmented into seal, stopper, cap, plunger, barrel and needle shield. According to our projection, currently stopper accounts for the highest pharmaceutical caps and closures market share, capturing 61% of the overall revenue share. This highest growth share is primarily due to the growing demand for safe and effective sealing solutions in the pharmaceutical industry. However, in the long run plunger and barrel will grow at a lucrative CAGR driven by the high demand for sealing biologics and self-administered drugs to maintain their efficacy.
Based on the sterilization status, the pharmaceutical caps and closures market is segmented into pre-sterilized and unsterilized. According to our projection, presently pre-sterilized caps and closures account for the highest share of the market, capturing 56% of overall revenue share. The dominance is primarily due to the growing demand for sterile caps to prevent contamination in drugs and drug delivery systems. It is worth highlighting here that driven by the increasing adoption of biologics and injectable drugs, the demand for pre-sterile caps will continue to rise during the forecast period and this segment will grow at a higher CAGR rate.
Based on the scale of production, the global pharmaceutical caps and closures market is segmented into small scale and large-scale production. According to our projection, presently, large scale production accounts for the highest share of the market. This is due to the growing demand for caps and closures to store therapeutic drugs to avoid spoilage from enzymatic degradation in pharmaceutical industry. It is important to highlight here that driven by the ongoing demand for caps and closures, large scale production will continue to grow at a higher CAGR during the forecast period.
Based on the key geographical region, the global market is segmented into North America, Europe, Asia-Pacific and the rest of the world. According to our projection, Asia-Pacific accounts for the highest share of the market, capturing 37% of overall revenue share. With rapid industrialization, expanding pharmaceutical industry and cosmetic market, the demand for caps and closures will grow in Asian countries like China and India. Owing to the industrial expansion, this market will grow at a higher CAGR in Asia-Pacific during the forecast period.
However, North America holds the second highest share of the market, capturing 34% of overall revenue share. This second highest growth share is primarily due to the high consumption rate of caps and closures in pharmaceutical, beverages and food packaging industries established in North America.
The ‘Pharmaceutical Caps and Closures Market: Industry Trends and Global Forecasts, till 2035’ market report features a comprehensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunities. It features an in-depth analysis, highlighting the various types of elastomeric closures including stoppers, needle shields and plungers, available in the market for various types of primary packaging containers, such as cartridges, syringes and vials.
Currently, the market landscape features the presence of several well-established and new entrants who hold the required expertise in the manufacturing of caps and closures. Few of these companies manufacture caps and closures for their clients across various industries including pharmaceutical, food and beverages, cosmetics, chemicals amongst others. Driven by the ongoing efforts, presently more than 240 closures have been developed by the industry leaders that are fabricated using a wide range of elastomeric materials. These closures are available to use in parenteral primary packaging containers. However, the majority of these closures are available in the ready to use format. In order to leverage a competitive edge, the market players are continually taking strategic initiatives for the expansion of their product portfolio. Overall, the market witnesses the presence of several small, medium-sized and large players.
With growing development of pharmaceutical products, there has been surge in the demand for caps and closures to enhance safety of the drugs. Notably, the caps and closures, specifically child-resistant and tamper evident, are in great demand to ensure safety and compliance with regulatory guidelines. Furthermore, the increasing demand for sustainable and eco-friendly material specifically bio-based plastics for the development of caps and closures is the key driver for the market.
Some of the potential challenges that may impede market growth during the projected period include price volatility of raw materials and environmental concerns. It is worth noting here that price volatility of raw materials such as metal, plastic and rubber may significantly impact the development cost which is expected to hinder the market growth. Moreover, the growing focus on reducing usage of plastics and stringent policies associated with environment protection may has further require the companies to move towards more sustainable raw materials.
In addition to primary packaging, the caps and closure developers are working to meet the growing demand for senior friendly as well as child resistant packaging solutions. Dexterity challenges with the elderly as well as safety measures for the children has created a demand in the market for special closures to meet the needs of this target population. We have already talked about the launch of SnapSlide caps for Rx vials in April 2024. February 2023 saw Berry Global launch set of seven PET bottles with tamper evident closures, keeping in mind the OTC pharmaceutical market.
Furthermore, the increasing demand for personalized medicines has further initiated the demand for customized caps and closures that are well designed for pharmaceutical products / targeted therapies. Additionally, companies are focusing on innovative / smart closures with integrated technologies such as RFID, IoT and NFC that ensure real-time monitoring of drug within supply chain. Stringent guidelines associated with the safety and efficacy of pharmaceutical products have further supported the growth of pharmaceutical caps and closures industry.
The global caps and closures market for pharmaceutical is estimated to grow from USD 6.20 billion to USD 12.49 billion by 2035. This highest growth potential is due to the increasing focus on safe transportation and drug storage solutions. Furthermore, the growing preference for biologics that demands advanced storage solutions is likely to be the key driver for this market, anticipated to grow at a CAGR of 6.6% during the forecast period.
Examples of key companies engaged in pharmaceutical caps and closures industry (which have also been profiled in this market report; the complete list of companies is available in the full report) include Aptar Pharma (a Part of AptarGroup), DWK Life Sciences, West Pharmaceutical Services, Datwyler Sealing Solutions (a Part of Datwyler Group), Lonstroff (a Part of Sumitomo Rubber Industries), Ompi (a Part of Stevanato Group), Daikyo Seiko, Hebei First Rubber Medical Technology and Jiangsu Hualan New Pharmaceutical Material. This market report includes an easily searchable excel database of all the companies’ providing caps, needle shields, plungers, stoppers, seals, tip caps and other closures for the pharmaceutical industry, worldwide.
In addition to other elements, the market research report includes:
 |
 |
 |
 |
 |
 |
 |
 |
Several recent developments have taken place in the field of pharmaceutical caps and closures. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.